Correlation Between Heart Test and Nexalin Technology

Can any of the company-specific risk be diversified away by investing in both Heart Test and Nexalin Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Heart Test and Nexalin Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Heart Test Laboratories and Nexalin Technology, you can compare the effects of market volatilities on Heart Test and Nexalin Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Heart Test with a short position of Nexalin Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Heart Test and Nexalin Technology.

Diversification Opportunities for Heart Test and Nexalin Technology

-0.53

Correlation Coefficient

Heart Test  Nexalin Technology

Excellent diversification

The 3 months correlation between Heart and Nexalin is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Heart Test Laboratories and Nexalin Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nexalin Technology and Heart Test is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Heart Test Laboratories are associated (or correlated) with Nexalin Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nexalin Technology has no effect on the direction of Heart Test i.e., Heart Test and Nexalin Technology go up and down completely randomly.

Pair Corralation between Heart Test and Nexalin Technology

Given the investment horizon of 90 days Heart Test Laboratories is expected to under-perform the Nexalin Technology. But the stock apears to be less risky and, when comparing its historical volatility, Heart Test Laboratories is 1.99 times less risky than Nexalin Technology. The stock trades about -0.03 of its potential returns per unit of risk. The Nexalin Technology is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest  64.00  in Nexalin Technology on October 1, 2024 and sell it today you would earn a total of  231.00  from holding Nexalin Technology or generate 360.94% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Heart Test Laboratories  vs.  Nexalin Technology

Heart Test Laboratories

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Heart Test Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Nexalin Technology

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Nexalin Technology are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite quite abnormal basic indicators, Nexalin Technology disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Heart Test and Nexalin Technology

The main advantage of trading using opposite Heart Test and Nexalin Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Heart Test position performs unexpectedly, Nexalin Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nexalin Technology will offset losses from the drop in Nexalin Technology's long position.

The idea behind Heart Test Laboratories and Nexalin Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.